Bruker Corporation (BRKR) News
Track canonical SquawkNews coverage tagged to BRKR, Bruker Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Nasdaq Composite gaining around 150 points on Wednesday. Shares of LuxExperience BV-ADR (NYSE: LUXE ) rose sharply after the company reported fourth-quarter results. LuxExperience reporte
LIVE | Sep 16, 2026, 01:57 PM UTC
L
UBS raises Bruker price target to $65, maintains Neutral
UBS maintains a Neutral rating on Bruker and raises its price target to $65.00 per share from $45.00, according to Benzinga.
EQUITY | Sep 09, 2026, 05:53 PM UTC
L
Bruker shares fall 6.3% after UBS starts coverage
Bruker shares dropped 6.3% in the afternoon session after UBS initiated coverage with a Neutral rating and a $65 price target.
EQUITY | Sep 09, 2026, 04:55 PM UTC
L
BRKR cites strong order growth and AI automation for future leadership
BRKR says strong order growth in China and tech markets, alongside AI-driven automation, supports future leadership, while revenue timing is affected by complex contracts. Integration of NMR and mass spectrometry systems
GEOPOLITICS | Sep 09, 2026, 01:38 PM UTC
L
BRKR: Integration of advanced technologies and deep tech drives growth, with strong order momentum
The conference highlighted integration of NMR and mass spectrometry, expansion into organ-on-a-chip via Mimetas, and strong growth in deep tech and proteomics. Financials showed EPS outperformance and robust order growth
EARNINGS | Sep 09, 2026, 12:57 PM UTC
L
Bruker leadership to present at upcoming healthcare investor conferences
Bruker Corporation says senior leadership will present at Wells Fargo’s 21st Annual Healthcare Conference (Boston) on Wednesday, September 9, 2026 at 8:00 a.m. Eastern Time.
EQUITY | Sep 08, 2026, 05:21 PM UTC
H
S&P 500 Hits Record Highs, Palantir Jumps 27%: Stock Market Today
U.S. equities powered to fresh record highs by midday Tuesday as blowout guidance from Palantir Technologies Inc. (NASDAQ: PLTR ) and a Caterpillar Inc. (NYSE: CAT ) earnings beat reignited the AI trade, while crude oil
EARNINGS | Aug 04, 2026, 05:07 PM UTC
L
Bruker Affirms FY2026 Adj EPS Guidance of $2.10-$2.15 vs $2.12 Est; Lowers FY2026 Sales Guidance from $3.570B-$3.600B to $3.540B-$3.570B vs
Bruker (NASDAQ: BRKR ) affirms FY2026 Adj EPS guidance from $2.10-$2.15 to $2.10-$2.15 vs $2.12 analyst estimate. Lowers FY2026 sales outlook from $3.570 billion-$3.600 billion to $3.540 billion-$3.570 billion vs $3.589
EARNINGS | Aug 04, 2026, 11:05 AM UTC
L
Bruker price target raised by $15 at TD Cowen, here's why
Bruker price target raised by $15 at TD Cowen, here's why
EQUITY | Jul 15, 2026, 12:44 PM UTC
L
BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in bl
BRKR Bruker expands infection detection portfolio with acquisition of metagenomic mngs disqver® platform for pathogenic microorganisms in blood Bruker expands infection detection portfolio with acquisition of metagenomic
MNA | Jul 15, 2026, 11:01 AM UTC
M
Guggenheim Maintains Buy on Bruker, Raises Price Target to $70
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ: BRKR ) with a Buy and raises the price target from $50 to $70.
EQUITY | Jun 29, 2026, 01:57 PM UTC
M
BRKR: Barclays Raises Target
Barclays maintains overweight rating on Bruker and raises price target to $60
EQUITY | Jun 24, 2026, 02:32 PM UTC